医疗技术公司Hyperfine Inc. (HYPR)于2024年11月12日公布了第三季度财务业绩，展示了显著的收入增长和毛利率扩张。公司报告的收入为360万美元，同比增长56%，毛利率达到52%。 Hyperfine的增长主要由其Swoop便携式成像系统的强劲销售以及向新的医疗场所的扩张所推动。尽管增长积极，但公司在本季度仍录得1030万美元的净亏损。 要点摘要 第三季度收入同比增长56%至3 ...

英为财情Investing.com - Hyperfine (NASDAQ: HYPR )星期二发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益符合分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.140，总营收为$3.64M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$3.3M，每股收益为$-0.140.

Hyperfine(HYPR)发布Q3财报，2024财年前三财季累计收入1056.90万美元，去年同期累计收入为834.60万美元，同比增长26.64%。 2024财年前三财季累计净亏损3033.00万美元，去年同期累计净亏损为3355.40万美元，同比缩小9.61%。 本财年累计基本每股收益为-0.42美元，去年同期为-0.47美元。 公司所属行业为医疗保健设备。 Hyperfine, Inc.

Hyperfine Inc. ( (HYPR)) has released its Q3 earnings. Here is a breakdown of the information Hyperfine Inc. presented to its investors. Hyperfine, Inc. is a pioneering health technology company that ...

Despite a net loss, Hyperfine Inc (HYPR) showcases strong revenue growth, international expansion, and technological advancements.

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. These figures are adjusted for ...

Hyperfine Inc (NASDAQ:HYPR) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 ...

Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin GroupMaria Sainz ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients ...

Hyperfine secured initial CE certification for the Swoop ® system in 2023. Earlier this year, Hyperfine significantly ...